Previous Close | 1.6900 |
Open | 1.7000 |
Bid | 1.6600 x 0 |
Ask | 1.7000 x 0 |
Day's Range | 1.6500 - 1.7200 |
52 Week Range | 1.2200 - 5.8400 |
Volume | |
Avg. Volume | 44,186 |
Market Cap | 76.327M |
Beta (5Y Monthly) | 1.73 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2300 |
Earnings Date | Apr 10, 2024 - Apr 15, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 6.46 |
Subscribe to Yahoo Finance Plus to view Fair Value for TH.TO
MONTREAL, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Mr. Alain Trudeau has resigned from the Board of Directors of Theratechnologies and as a member of its Audit Committee, effective immediately. “I want to thank Alain for his contributions to Theratechnologies as a director since joining the Comp
MONTREAL, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the United States Food and Drug Administration (FDA) has issued a refusal to file letter (RTF) regarding the Company’s supplemental Biologics License Application (sBLA) for an intramuscular (IM) method of administration for the maintenance dose
Theratechnologies (THTX) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.